CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 52.331
AS - Asia 26.408
EU - Europa 15.106
SA - Sud America 3.782
AF - Africa 544
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 19
Totale 98.250
Nazione #
US - Stati Uniti d'America 48.723
SG - Singapore 9.749
CN - Cina 4.777
HK - Hong Kong 4.704
VN - Vietnam 3.777
RU - Federazione Russa 3.476
CA - Canada 3.298
BR - Brasile 2.908
IT - Italia 2.160
IE - Irlanda 1.993
UA - Ucraina 1.616
SE - Svezia 1.573
DE - Germania 1.224
GB - Regno Unito 892
FR - Francia 869
IN - India 581
BD - Bangladesh 533
FI - Finlandia 484
AR - Argentina 345
TR - Turchia 323
IQ - Iraq 285
ID - Indonesia 281
KR - Corea 280
MX - Messico 188
PK - Pakistan 172
ZA - Sudafrica 159
EC - Ecuador 157
NL - Olanda 130
JP - Giappone 129
SA - Arabia Saudita 129
AT - Austria 109
CO - Colombia 108
PH - Filippine 108
UZ - Uzbekistan 104
ES - Italia 96
PL - Polonia 95
VE - Venezuela 81
DK - Danimarca 79
MA - Marocco 65
CL - Cile 61
MY - Malesia 61
EG - Egitto 55
KE - Kenya 55
TN - Tunisia 50
PY - Paraguay 48
AU - Australia 46
BE - Belgio 42
CZ - Repubblica Ceca 40
ET - Etiopia 38
TH - Thailandia 37
NP - Nepal 36
AE - Emirati Arabi Uniti 34
DZ - Algeria 31
JO - Giordania 29
JM - Giamaica 27
PE - Perù 27
RO - Romania 27
AZ - Azerbaigian 26
OM - Oman 26
KZ - Kazakistan 25
IR - Iran 23
PS - Palestinian Territory 22
UY - Uruguay 22
IL - Israele 21
BG - Bulgaria 20
BO - Bolivia 20
LT - Lituania 20
TW - Taiwan 20
NG - Nigeria 19
TT - Trinidad e Tobago 18
AL - Albania 17
CR - Costa Rica 17
GR - Grecia 17
DO - Repubblica Dominicana 16
KG - Kirghizistan 16
LB - Libano 16
RS - Serbia 15
SN - Senegal 15
HU - Ungheria 14
GE - Georgia 13
NZ - Nuova Zelanda 13
PT - Portogallo 13
CH - Svizzera 12
HN - Honduras 12
EU - Europa 11
SY - Repubblica araba siriana 11
BH - Bahrain 10
BY - Bielorussia 10
LK - Sri Lanka 10
QA - Qatar 10
BA - Bosnia-Erzegovina 9
EE - Estonia 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 9
GT - Guatemala 8
PA - Panama 8
AM - Armenia 7
MU - Mauritius 7
NO - Norvegia 7
CI - Costa d'Avorio 6
Totale 98.133
Città #
Ann Arbor 7.848
Singapore 5.118
Hong Kong 4.655
Woodbridge 4.359
Fairfield 4.240
Ashburn 3.398
Houston 3.111
Toronto 2.754
San Jose 1.911
Dublin 1.874
Wilmington 1.824
Jacksonville 1.821
Seattle 1.639
Cambridge 1.398
Dearborn 1.364
Chandler 1.363
New York 1.176
Ho Chi Minh City 1.122
Princeton 1.001
Chicago 899
Hanoi 863
The Dalles 775
Milan 758
Dallas 704
Frankfurt am Main 655
Beijing 648
Santa Clara 627
Hefei 534
Los Angeles 514
Lauterbourg 497
Lawrence 479
Altamura 453
Nanjing 423
Moscow 328
Lachine 310
San Diego 306
São Paulo 266
Seoul 255
Council Bluffs 247
Buffalo 197
Dong Ket 171
Shanghai 164
Guangzhou 155
Jakarta 153
Shenyang 145
Nanchang 143
Andover 139
Da Nang 137
Salt Lake City 133
Haiphong 129
Hebei 120
Baghdad 116
London 116
Helsinki 110
Orem 105
Munich 95
Falls Church 94
Tianjin 92
Rio de Janeiro 91
Ottawa 90
Boardman 89
Tokyo 89
Norwalk 88
Changsha 86
Tashkent 85
Jiaxing 81
Nuremberg 71
Columbus 69
Rome 68
Jinan 66
Quito 66
Tampa 66
Detroit 63
Hangzhou 63
Chennai 62
Johannesburg 62
Phoenix 62
Warsaw 62
Dhaka 61
Vienna 61
Can Tho 58
Atlanta 57
Biên Hòa 57
Brasília 55
Zhengzhou 55
Brooklyn 54
Hải Dương 53
Lahore 53
Quận Bình Thạnh 52
San Francisco 51
Montreal 49
Nairobi 49
Denver 48
Belo Horizonte 47
Mexico City 47
Kunming 46
Washington 46
Curitiba 45
Istanbul 44
Ninh Bình 44
Totale 67.642
Nome #
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 598
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 458
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 413
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 379
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 371
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 367
Need for information and locus of control among hypertensive patients 360
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 345
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 341
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 337
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 328
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 327
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 320
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 320
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 319
Cardiopulmonary receptor regulation of renin release 315
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 312
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 310
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 303
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 301
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 298
Neurogenic abnormalities in masked hypertension 297
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 297
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 294
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 291
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 289
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 289
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 283
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 280
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 280
Renal and antihypertensive effects of felodipine in hypertensive patients 279
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 279
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 278
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 277
Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age 276
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 275
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 274
Extreme dipping: Always means nocturnal hypotension? 271
New-onset left atrial enlargement in a general population 268
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 266
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 266
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 265
The association between 24-h blood pressure patterns and left ventricular mechanics 264
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 263
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 261
Treatment of hypertension: The ESH/ESC guidelines recommendations 260
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 259
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 259
Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian survey 258
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study 257
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 256
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 255
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 253
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 253
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 252
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 251
Metabolic syndrome and multiple organ damage in essential hypertension 249
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 248
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 247
Comprendere l'ipertensione; percezioni della malattia e bisogno informativo in un campione di pazienti ipertesi 247
Blood pressure control in hypertension. Pros and cons of available treatment strategies 247
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 246
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 245
Clinical evaluation of a new antihypertensive drug (Indapamide) 244
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 243
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 241
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 241
Nocturnal blood pressure in untreated essential hypertensives 240
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 240
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 239
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 237
Evaluating a tailored message intervention for improving hypertension outcomes 237
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 236
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 235
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 235
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 235
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 234
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 233
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 233
Incident Left Ventricular Hypertrophy in Masked Hypertension 232
Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis 231
Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension 230
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 230
Metabolic syndrome and target organ damage: Role of blood pressure 229
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 229
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 228
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 228
Masked hypertension: an independent predictor of organ damage 228
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives? 227
Is retinal arteriolar-venular associated with cardiac and extracardiac organ damage in essential hypertension? 227
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 226
Prevalence and correlates of multiple organ damage in referred treated hypertensives: Data from the ETODH study 225
How does subclinical hyperthyroidism affect right heart function and mechanics? 225
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 221
Right ventricular mechanics in patients with aortic stenosis and preserved ejection fraction: Is arterial hypertension a new player in the game? 221
Nocturnal hypertension and organ damage in dippers and nondippers 220
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 220
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 220
Management of hypertension in patients with left ventricular hypertrophy 219
Evaluating a tailored message intervention for improving hypertension outcomes 219
Totale 27.164
Categoria #
all - tutte 332.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 332.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.174 0 0 0 0 0 0 0 0 0 0 401 773
2021/20226.275 473 536 888 444 393 369 359 406 416 382 515 1.094
2022/20236.284 1.085 1.785 392 401 366 1.082 83 307 403 69 213 98
2023/20245.325 143 112 112 187 918 1.380 964 84 741 105 57 522
2024/202514.957 922 1.946 411 671 1.382 386 520 484 2.090 1.930 1.358 2.857
2025/202633.106 3.561 2.468 2.740 3.195 3.564 1.899 4.605 1.756 2.701 2.686 3.931 0
Totale 100.384